Detalhe da pesquisa
1.
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.
Nature
; 574(7780): 707-711, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31664194
2.
Longitudinal molecular trajectories of diffuse glioma in adults.
Nature
; 576(7785): 112-120, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31748746
3.
Primary brain tumours in adults.
Lancet
; 402(10412): 1564-1579, 2023 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738997
4.
3D-Engineered Scaffolds to Study Microtubes and Localization of Epidermal Growth Factor Receptor in Patient-Derived Glioma Cells.
Small
; 18(49): e2204485, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207287
5.
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
Acta Neuropathol
; 141(6): 945-957, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740099
6.
Subgroup and subtype-specific outcomes in adult medulloblastoma.
Acta Neuropathol
; 142(5): 859-871, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34409497
7.
A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling.
Prostate
; 79(9): 937-948, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31017696
8.
Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients.
J Neurooncol
; 144(1): 79-87, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31240524
9.
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.
J Neurooncol
; 144(1): 205-210, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31273577
10.
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.
Lancet Oncol
; 19(9): 1170-1179, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115593
11.
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma.
J Neurooncol
; 139(2): 349-357, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29663171
12.
Does early resection of presumed low-grade glioma improve survival? A clinical perspective.
J Neurooncol
; 133(1): 137-146, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28401374
13.
A glioma classification scheme based on coexpression modules of EGFR and PDGFRA.
Proc Natl Acad Sci U S A
; 111(9): 3538-43, 2014 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24550449
14.
Tumor-specific mutations in low-frequency genes affect their functional properties.
J Neurooncol
; 122(3): 461-70, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25694352
15.
Molecular subtypes of glioma identified by genome-wide methylation profiling.
Genes Chromosomes Cancer
; 52(7): 665-74, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23629961
16.
Malignant glioma in L-2-Hydroxyglutaric Aciduria: thorough molecular characterization of a case and literature review.
Free Neuropathol
; 52024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716347
17.
Evaluating the Predictive Value of Glioma Growth Models for Low-Grade Glioma After Tumor Resection.
IEEE Trans Med Imaging
; 43(1): 253-263, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490381
18.
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.
bioRxiv
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562747
19.
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen.
Cancer Res
; 84(5): 741-756, 2024 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38117484
20.
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.
Acta Neuropathol
; 126(6): 917-29, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24174164